GVK BIO is a global Contract Research and Development Organization (CRDO) providing research and development services to the biopharma and life sciences industry. We enable our customers to bring their products to market in a fast yet cost-efficient manner.
GVK BIO employs a no-conflict model and ensures no internal programs that can potentially conflict with our customers projects. Our team of over 2500+ well qualified scientists, backed by rigorous processes, scalable practices, modern facilities and a strong customer-centric partnering approach, makes it India’s leading CRDO.
GVK BIO’s capabilities include:
Spread across 55 acres, GVK BIO has seven state-of-the-art research facilities: five in India and two in USA. All facilities conform to stringent regulatory standards. Our infrastructure has a built-up area of 1,200,000 sq. ft. housing chemistry labs, biology labs, analytical labs, formulation development labs, kilo labs, AAALAC accredited animal house, pilot plants and manufacturing facilities. GVK BIO has been assessed by all the leading regulatory agencies of the world including USFDA, WHO, PMDA, EDQM, MFDS and EMEA.
In 2014, GVK BIO acquired Aragen Bioscience, Inc., a US-based Biologics CRO. With Aragen, GVK BIO is uniquely positioned to support client programs in both small and large molecules.
GVK BIO recognizes its commitment to the community through its Corporate Social Responsibility (CSR) initiatives to make meaningful impact to the under-privileged. All CSR programs are focused on education, health, environment and women empowerment areas.
GVK BIO is proud to be a 'Great Place To Work®' (GPTW) Certified Organization committed to employee–centric culture.